C-MSCL

T:MSCL - SATELLOS BIOSCIENCE INC. - https://satellos.com/

22:57:10 EDT

Sym-X	Bid - Ask					Last	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
MSCL - T	10.0	0.47	·	0.50	50.0	0.50	30.1	14	27	0.50 0.50 0.48	0.80 0.29	15:59:50	Oct 01	15 min RT 2¢
TSX - T	10.0	0.47	·	0.50	50.0	0.50	21.7	10	14	0.50 0.50 0.49	0.80 0.29	15:59:50		15 min
NEO ATS - U						0.50	1.0	0	2	0.50 0.50 0.50		14:50:48		15 min
Omega - O						0.50	5.0	2	5	0.48 0.50 0.48		14:23:16		15 min
Pure - P						0.50	0.5	0	1	0.50 0.50 0.50		14:50:48		15 min
CXD - D						0.50	0.4	0	4			Sep 17		15 min
TriAct - M						0.50	1.5	1	1					15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Options · Shorts · Portfolio

Recent Trades - Last 10 of 27

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:50	T	0.50		500	79 CIBC	79 CIBC	K
15:56:55	T	0.50		500	79 CIBC	79 CIBC	K
15:53:24	T	0.50		500	79 CIBC	79 CIBC	K
15:53:03	T	0.50		2,000	1 Anonymous	1 Anonymous	K
15:46:52	T	0.50		500	79 CIBC	79 CIBC	K
15:33:48	T	0.50		500	79 CIBC	79 CIBC	K
15:14:56	T	0.50		500	79 CIBC	79 CIBC	K
14:50:48	T	0.50		4,000	9 BMO Nesbitt	1 Anonymous	K
14:50:48	P	0.50		500	9 BMO Nesbitt	1 Anonymous	K
14:50:48	U	0.50		500	9 BMO Nesbitt	1 Anonymous	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2024-10-01 07:00	C:MSCL	0.46	News Release200	Satellos Demonstrates Treatment of DMD Canines with SAT-3247 Improved Measures of Strength to Near Normal Levels
2024-09-24 07:41	C:MSCL	0.475	In the News525	Globe says Satellos Bioscience rated "speculative buy"
2024-09-18 10:00	C:MSCL	0.48	News Release200	Satellos doses first patient in SAT-3247 clinical study
2024-08-19 16:19	C:MSCL	0.495	News Release200	Satellos receives regulatory filing for SAT-3247 trial
2024-08-12 12:57	C:MSCL	0.45	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-08-12 12:52	C:MSCL	0.45	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-08-12 07:00	C:MSCL	0.45	News Release200	Satellos Announces Q2 2024 Financial Results and Updated Canine Data
2024-08-08 12:03	C:MSCL	0.47	News Release200	Satellos's SAT-3247 gets rare pediatric disease status
2024-07-11 12:05	C:MSCL	0.495	News Release200	Satellos Bioscience submits clinical research proposal
2024-07-02 12:30	C:MSCL	0.53	News Release200	Satellos talks preliminary SAT-3247 DMD results
2024-06-27 07:00	C:MSCL	0.52	News Release200	Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference
2024-05-28 11:17	C:MSCL	0.485	News Release200	Satellos Bioscience forms clinical advisory board
2024-05-14 17:43	C:MSCL	0.47	News Release200	Satellos Bioscience holders approve all matters at AGSM
2024-05-14 14:08	C:MSCL	0.48	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-05-14 14:02	C:MSCL	0.48	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-05-14 11:59	C:MSCL	0.48	News Release200	Satellos Bioscience's March 31 cash at $33.2-million
2024-03-27 16:42	C:MSCL	0.48	SEDAR MD & A815	SEDAR MD & A
2024-03-27 15:50	C:MSCL	0.46	SEDAR MD & A815	SEDAR MD & A
2024-03-27 15:44	C:MSCL	0.46	SEDAR Annual Information Form802	SEDAR Annual Information Form
2024-03-27 15:44	C:MSCL	0.46	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements

Date ET

Symbol

Price

Type

Headline

2024-10-01 07:00

C:MSCL

0.46

News Release

Satellos Demonstrates Treatment of DMD Canines with SAT-3247 Improved Measures of Strength to Near Normal Levels

2024-09-24 07:41

C:MSCL